Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar renolori (< 20) Submitted: 12/12/2010 9:32:08 PM : Outperform Start Price: $18.82 JAZZ Score: +137.95

outperform

Featured Broker Partners


Advertisement